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ABSTRACT
A rapid, simple and highly discriminatory DNA ﬁngerprinting methodology which produces data that
can be easily interpreted, compared and transported is the ultimate goal for studying the epidemiology
of Mycobacterium tuberculosis. A novel TaqI ﬂuorescent ampliﬁed fragment length polymorphism
(fAFLP) approach to M. tuberculosis DNA ﬁngerprinting that targeted the variable IS6110 marker was
developed in this study. The new method was tested for speciﬁcity and reproducibility, and compared
with the standard reference IS6110 restriction fragment length polymorphism (RFLP) method for a panel
of 78 isolates. Clustering conﬂicts between the two methods were resolved using mycobacterial
interspersed repetitive unit–variable number tandem repeat (MIRU-VNTR) data. Comparison with an
in-silico digestion of strain H37Rv showed that fAFLP-detected fragments were highly speciﬁc in vitro.
The reproducibility of repeated digestions of strain H37Rv was 100%. Clustering results obtained by
fAFLP and RFLP were highly congruent, with fAFLP allocating 97% of RFLP-clustered isolates to the
same eight clusters as RFLP. Two single-copy isolates that had been clustered by RFLP were not
clustered by fAFLP, but the MIRU-VNTR patterns of these isolates were different, indicating that the
RFLP data had falsely clustered these isolates. Analysis by fAFLP will allow rapid screening of isolates
to conﬁrm or refute epidemiological links, and thereby provide insights into the frequency, conservation
and consequences of speciﬁc transposition events.
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INTRODUCTION
Tuberculosis (TB) is the most prevalent infectious
disease in humans, with one-third of the world’s
population being infected and at risk of develop-
ing the active form of the disease [1]. Each
year, >8 million individuals develop TB and
c. 2 million die of the disease [1]. Control of the
pan-global resurgence of TB requires insights into
the mechanisms of disease transmission within
populations. Molecular ﬁngerprinting is crucial
for TB control by providing initial conﬁrmation of
cases belonging to a speciﬁc outbreak. It is also
possible to detect chains of transmission by
determining the relatedness of isolates within an
outbreak, to differentiate cases of primary infec-
tion from latent reactivation, and to detect cases of
laboratory cross-contamination. For epidemiolo-
gists and infection control specialists, genetic
ﬁngerprinting of isolates within a deﬁned geo-
graphical area over a speciﬁed period can identify
at-risk populations and estimate the rate of recent
transmission of TB within that community.
The current international standard reference
technique for DNA ﬁngerprinting is IS6110
restriction fragment length polymorphism (RFLP)
analysis, which was standardised in 1993 [2]. The
numbers and chromosomal positions of IS6110
elements have been shown to be highly variable
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among unrelated isolates, making it unlikely that
two unrelated isolates will have identical RFLP
banding patterns by chance [3]. However, the
major drawbacks of IS6110 RFLP have been
reported widely; these include the need for an
extended culture period, followed by a time-
consuming, low-throughput and costly methodo-
logy. The entire process can take up to 4–5 weeks
to complete [3].
There remains a need for a high-throughput
method that is sensitive and rapid, and that
utilises the superior resolution of the IS6110
genetic marker. PCR-based techniques offer the
potential for ‘real-time’ molecular typing, produ-
cing results within hours, and requiring only
small amounts of DNA. A mixed-linker PCR [4,5]
has been used in several outbreak studies, but this
approach is still laborious, with four pre-PCR
steps, followed by a primary PCR and then a
nested PCR. The methodology has been optim-
ised into a technique termed fast ligation-medi-
ated PCR [6], which provides a more streamlined
approach, but the reproducibility and speciﬁcity
of this method have yet to be demonstrated using
an automated detection system, so the limitations
of comparing isolates using pattern recognition
(as with IS6110 RFLP) remain.
In an attempt to overcome these limitations, the
present study developed a ﬂuorescent ampliﬁed
fragment length polymorphism (fAFLP) ﬁnger-
printing assay that targeted IS6110 for use with an
automated DNA sequencer, and compared the
results to those obtained using the current
approach of IS6110 RFLP analysis.
MATERIALS AND METHODS
DNA extraction
DNA was extracted at the Midlands Regional Centre for
Mycobacteriology, Birmingham, UK from 78 clinical cultures
and the H37Rv laboratory strain of Mycobacterium tuberculosis,
using the QIAamp DNA Mini kit (Qiagen, Crawley, UK) as
described previously [7]. Isolates were cultured in Mycobac-
terial Growth Indicator Tubes (BD Diagnostics, Oxford, UK) at
37C until a positive growth index was obtained (maximum
culture time of 2 weeks). The DNA samples were sent as an
unidentiﬁed panel to the Health Protection Agency Centre for
Infections, London, UK.
IS6110 RFLP and mycobacterial interspersed repetitive unit–
variable number tandem repeat (MIRU-VNTR) analysis
IS6110 RFLP was performed at the Health Protection Agency
(Birmingham, UK) as described previously [2]. Variable
number tandem repeat (VNTR) analysis was also performed
at the Health Protection Agency Birmingham, as described
previously [7], using three exact tandem repeat loci [8] and 12
mycobacterial interspersed repetitive unit (MIRU) loci [9].
MIRU-VNTR data were used solely to resolve incidents
of conﬂict between RFLP and fAFLP clustering, and
were not taken into account for the analysis of RFLP or
fAFLP data.
In-silico H37Rv digest maps
Lasergene software (DNAStar, Madison, WI, USA) was used
to predict the size of fragments produced from H37Rv
following an MseI ⁄TaqI digest of the M. tuberculosis genome.
GenBank sequences NC_000962 (M. tuberculosis H37Rv
complete genome) and X17348 (M. tuberculosis H37Rv
IS6110 element) were used to produce digest maps, and
fragment size data were then adjusted to allow for the
addition of IS6110-speciﬁc and TaqI adaptor-speciﬁc
primer sequences during PCR. IS6110 elements in
both forward and reverse directions in the genome were
included.
fAFLP
The IS6110 fAFLP typing methodology used in this study is
outlined in Fig. 1. This protocol was developed and tested
with ﬁve replicate samples of H37Rv DNA, and then with a
panel of 78 isolates. Speciﬁcally, 500 ng of DNA was digested
for 2 h at 37C in a total volume of 20 lL containing 5 U of
MseI (New England Biolabs, Hitchin, UK), 1 · MseI buffer 2,
bovine serum albumin 0.1 mg/mL, DNase-free RNase A
0.5 mg ⁄mL, 1 M L-proline (Sigma-Aldrich, Poole, UK) and
2 mM betaine (Sigma-Aldrich); 10 U of TaqI (New England
Biolabs) was then added to the digest and the reaction
mixtures were incubated for a further 3 h at 65C. Endonuc-
leases were inactivated at 80C for 2 min before ligation.
The double-digested DNA was ligated with TaqI site-
speciﬁc adaptors by adding 25 lL of a solution containing
40 U of T4 DNA ligase (New England Biolabs), 0.2 lM double-
stranded TaqI adaptor (sequence shown in Fig. 1), and 2 · T4
ligase buffer. The reaction mixture was incubated at 12C for
17 h, heated at 65C for 10 min to inactivate the ligase, and
then stored at )20C.
PCR ampliﬁcation of digestion fragments containing the
IS6110 sequence
Each reaction mix contained 2.5 lL of each adaptor ligation
product, 1 · HotStar Taq mastermix (Qiagen), 1 M betaine
PCR reagent (Sigma-Aldrich), 1 lM TaqI primer (5¢-CGAT-
GAGTCCTGACCGA) and 1 lM 5¢-Cy5-labelled IS6110(1)
primer (5¢-CTGACATGACCCCATCCTTT) in a ﬁnal reaction
volume of 25 lL. Touchdown PCR cycling parameters with a
thermocycler (Applied Biosystems, Warrington, UK) com-
prised 94C for 15 min, followed by 30 cycles of 94C for 20 s,
66C for 30 s and 72C for 2 min, with the 66C annealing
temperature decreasing by 1C per cycle for nine cycles and
then remaining at 56C for the last 20 cycles. A ﬁnal extension
at 60C for 30 min completed the reaction. Amplicons were
visualised on 96-well Ready-to-Run preset agarose gels
(Amersham Biosciences, Chalfont St Giles, UK) and stored at
)20C.
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Automated fragment size analysis
Automated sizing of restriction fragment lengths was per-
formed using a Beckman CEQ8000 Genetic Analyser System
(Beckman Coulter, High Wycombe, UK). GenomeLab DNA
Size Standard-600 (1.25 lL) (Beckman Coulter) was added to
320 lL of GenomeLab Sample Loading solution (Beckman
Coulter) for every eight PCRs run. Aliquots (37 lL) of the
mix were placed in the wells of a 96-well reaction plate
(Beckman Coulter) and 1 lL of PCR product was added. The
reaction plate was mixed and each well was covered with a
drop of mineral oil (Beckman Coulter). Reaction plates were
loaded on the Beckman System and analysed using the
‘Frag4’ program.
Reproducibility study
The ability of fAFLP analysis to produce identical
results was assessed by preparing ﬁve separate digestion
reactions of H37Rv DNA. Statistical tests based on simple
matching were performed to calculate the average percent-
age similarity between replicate results and the range of
percentage similarities found. Three of the adaptor-ligated
digestion products were then each used in ﬁve separate
PCRs to test the reproducibility of speciﬁc fragment ampli-
ﬁcation and detection by the automated fragment analysis
system.
Cluster analysis
The IS6110 RFLP results were entered into BioNumerics v.4.5
(Applied Maths, Sint-Martens-Latem, Belgium), analysed
using the Dice coefﬁcient, and displayed using the unweighted
pair-group method with arithmetic averages (UPGMA). Band
tolerance was set at 2%.
RESULTS
In-silico vs. in-vitro fragment ampliﬁcation
proﬁles
In-silico restriction digest prediction for H37Rv
(GenBank accession number NC_000962) was
found to be highly similar to the results obtained
experimentally, with 13 of 14 predicted frag-
ments being ampliﬁed and detected. A 773-bp
fragment predicted in silico was not expected to
be detected, as its size exceeds the range of the
size standard used (60–640 bp). In-silico restric-
tion analysis revealed an MseI cut site in the
upstream ﬂanking sequence of one of the 16
IS6110 elements within the H37Rv chromosome.
Ampliﬁcation of this fragment was not expected,
as the TaqI adaptor sequence is not complement-
ary to the sticky-end sequence of the MseI cut
site. The only discrepancies between the in-silico
and fAFLP results were a predicted 288-bp
fragment that was not detected experimentally,
and one unexpected fragment of 190 bp that
was produced and observed consistently in all
Fig. 1. Outline of the ﬂuorescent ampliﬁed fragment length polymorphism (fAFLP) typing methodology used in this
study. An IS6110 insertion element is represented by a solid black line and the ﬂanking genomic DNA is represented by
dotted lines. TaqI DNA restriction sites are represented by vertical arrows. The forward primer (italicised) is
complementary to one strand of a dsDNA TaqI-speciﬁc adaptor (nucleotide sequences shown); the reverse primer is
speciﬁc to a sequence in the upstream region of IS6110 (horizontal black arrow). A PCR-ampliﬁed fragment is represented
by parallel black lines on the left-hand side. In summary, MseI and TaqI were used to digest the genomic DNA. MseI was
used initially to segment the genome, resulting in increased accessibility for the second enzyme, TaqI, to speciﬁc DNA
target sites for more complete enzymic digestion. TaqI works efﬁciently at a high temperature (65C) and facilitates the
dissociation of complementary strands of the GC-rich (i.e., high Tm) genomic DNA to allow more efﬁcient and complete
digestion. As TaqI cuts at a site 70 bp into the 5¢-end of the 1.36-kb IS6110 element, the PCR primer was designed from a
20-bp sequence within this region (nucleotides 42–61), 9 bp upstream from the cut site. A second PCR primer was designed
according to the adaptor sequence ligated to the TaqI restriction sites. Ampliﬁed fragments will vary in size because of
differences in TaqI restriction site positions upstream from different IS6110 elements within the genome. Differences in
IS6110 number and genomic positions and ⁄or distance from upstream TaqI restriction sites among genotypes provide the
strain-to-strain polymorphism that is necessary for molecular typing.
966 Clinical Microbiology and Infection, Volume 13 Number 10, October 2007
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 964–970
ﬁve replicates of the reproducibility study (see
below).
Reproducibility study
Five separate restriction digest reactions were
carried out using the laboratory strain H37Rv to
test the reproducibility of the fAFLP fragment
proﬁles produced. The addition of proline to the
restriction reaction greatly increased the speciﬁc-
ity of the fragments produced. The fragment
results following fAFLP analysis were 100%
reproducible. An example of partial replicate
fragment proﬁles for H37Rv is shown in Fig. 2.
In addition, three of the remaining adaptor-
ligated digestions were re-ampliﬁed by PCR in
ﬁve reactions, run in parallel, to evaluate the
reproducibility of the fragment ampliﬁcation and
automated detection steps. The 14 expected frag-
ments were 100% reproducible in all 15 reactions.
The largest fragment, 561 bp, was visible as a
small peak in all reactions, but was recognised by
the software in only one case because of the
relatively low peak intensity. Similarly, the 88-bp
fragment was not detected by the fragment
analysis software on several occasions because
of its relatively low intensity; however, the peaks
were always present in the strain proﬁles and
were added manually to fragment proﬁles in
BioNumerics during the analysis stage.
Comparison of fAFLP results with IS6110
RFLP analysis
The fAFLP assay was performed with a panel of
78 isolates genotyped previously by IS6110 RFLP.
The fAFLP proﬁles of these isolates comprised
0–14 IS6110-containing TaqI fragments of
75–584 bp (as detected with a 640-bp maximum
size standard). The fAFLP method grouped 61 of
the isolates into nine clusters, each containing
2–32 isolates (Fig. S1, see Supplementary mater-
ial). Within eight of the clusters, the fAFLP
fragment proﬁles were identical. Cluster F04
(n = 5) was the exception, with two isolates (832
and 67) yielding nine fragments rather than ten;
however, all ﬁve isolates yielded ten bands
according to RFLP analysis. The RFLP proﬁles
for these isolates were difﬁcult to interpret, as
most bands were very weak, but all ﬁve isolates
had identical MIRU-VNTR proﬁles (Table 1,
Fig. S1).
Of the remaining 17 (unclustered) isolates, 15
had unique fAFLP proﬁles of between two and 14
Fig. 2. Example of three replicate ﬂuorescent ampliﬁed fragment length polymorphism (fAFLP) fragment proﬁles for
Mycobacterium tuberculosis H37Rv that were obtained as part of the reproducibility study. The peaks are fAFLP fragments.
Sizes are given in bp above each fragment. Only partial proﬁles are shown.
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fragments (data not shown). No fragments were
observed for two isolates (isolates 85 and 12), and
these were therefore tentatively interpreted as
zero-copy IS6110 isolates; however, both isolates
produced one band by IS6110 RFLP, thereby
indicating the presence of at least one IS6110 copy
in the genome.
When the results of fAFLP clustering were
compared with those of IS6110 RFLP analysis, the
results were revealed to be highly congruent
(Fig. S1), with 57 (97%) of 59 clustered isolates
allocated to the same eight clusters (RFLP clusters
R02–R09). RFLP cluster R01 (isolates 85 and 12)
was not identiﬁed by fAFLP, as no IS6110-con-
taining fragments were detected (as described
above); however, this was a case of false cluster-
ing by RFLP, as these isolates were different
according to MIRU-VNTR (Table 1). Of the 17
isolates with unique RFLP proﬁles, fAFLP yielded
unique proﬁles for 13 (76%). Two RFLP-unique
isolates, 04 and 731, were indistinguishable from
isolates in fAFLP clusters F01 and F02, respect-
ively. Isolate 04 clustered with another 31 isolates
by fAFLP, but had one extra band by RFLP.
Isolate 731 differed from the six isolates in RFLP
cluster six by one additional RFLP band, while the
other 11 bands were common to the cluster.
MIRU-VNTR analysis was congruent with the
fAFLP clustering of these isolates. A further two
RFLP-unique isolates were clustered together by
fAFLP analysis, based on 11 identical fragments
(isolates 03 and 143, fAFLP cluster 09). The RFLP
proﬁles of these isolates appeared to differ at
three band positions, and hence were not clus-
tered by RFLP. In these four cases, RFLP
appeared to be able to discriminate these isolates,
whereas fAFLP could not. However, close exam-
ination of the RFLP proﬁles for these isolates
(Fig. S1) shows that analysis of some of the bands
may be subjective. The MIRU-VNTR data con-
cerning these isolates were congruent with the
fAFLP clustering.
A notable discrepant result was the detection of
11 fAFLP fragments in an isolate (no. 65) with no
apparent IS6110 copies according to RFLP analy-
sis. However, this result may be a consequence of
an RFLP reaction that failed because of inad-
equate DNA extraction. This isolate was separ-
ated from all other isolates by MIRU-VNTR
analysis (Table 1), and thus it was not necessary
to repeat the RFLP analysis for epidemiological
purposes.
Of the 65 isolates in the panel with high IS6110
copy numbers (deﬁned as more than ﬁve RFLP
bands), fAFLP analysis clustered 54 isolates and
identiﬁed 11 unique proﬁles, while RFLP analysis
clustered 52 isolates and identiﬁed 13 unique
proﬁles, thereby demonstrating 91% concordance
for isolates with high IS6110 copy numbers. In
comparison, MIRU-VNTR analysis clustered 64
isolates and identiﬁed 14 unique proﬁles, and
demonstrated 91% (69 ⁄ 76) concordance with
fAFLP analysis and 86% (67 ⁄ 78) concordance
with RFLP analysis in the clustering or unique
allocation of strains (Fig. S1).
DISCUSSION
The fAFLP approach was found to be highly
reproducible and to be highly congruent (90%)
with RFLP typing. Isolates with single RFLP band
differences have been reported previously in
cases that are, or are considered to be, epidemio-
logically linked [10–13], highlighting one of the
difﬁculties in interpreting RFLP data. The exact
sizing of fragments within the fAFLP typing
proﬁles would enable a more informed decision
to be made on the basis of typing data alone.
Epidemiological data would usually be available
Table 1. Mycobacterial interspersed repetitive unit–vari-
able-number tandem repeat (MIRU-VNTR) data for the
clusters and unique isolates of Mycobacterium tuberculosis
included in the study
Cluster ETR loci MIRU loci
M01 32532 223125153224
M02 23433 223425143322
M03 22433 223425153322
M04 32433 223125153322
M05 32333 224325153314
M06 32333 225323153323
M07 42235 225425173533
M08 42235 226425163533
M09 42235 226425153533
M10 94535 126224243521
Unique isolates
01 32433 224323153324
12 95265 254325223513
182 22332 225325153225
52 33133 224325153321
562 42235 226325153533
57 22433 224125163322
58 32433 224325153324
632 42235 225525153533
633 94265 254326223513
65 32-3- 226425163533
733 42235 225425184533
85 71466 254316223632
882 32323 214225133324
90 42235 225425153534
–, denotes non-ampliﬁcation at that particular VNTR locus.
ETR, exact tandem repeat; MIRU, mycobacterial interspersed repeat; VNTR,
variable number tandem repeat.
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to supplement ﬁngerprint data in determining
whether close matches are part of the same out-
break, although such data may not be available
within the time necessary to culture and ﬁnger-
print the isolates.
fAFLP analysis failed to detect an IS6110 copy
in two single-copy strains (as determined by
RFLP analysis). However, the IS6110 marker is
not thought to be as reliable for molecular typing
when ﬁve or fewer bands are obtained (and
cannot be used to type isolates without IS6110
insertions), which, consequently, is also a draw-
back of IS6110 fAFLP analysis. In normal cir-
cumstances, such isolates would require
secondary typing, and MIRU-VNTR analysis
revealed subsequently that these two isolates
were unrelated.
The advantages of PCR-based methods over
IS6110 RFLP analysis for typing M. tuberculosis
isolates have been well-documented. In compar-
ison, fAFLP analysis is a high-throughput, accu-
rate, precise and technically simple method. It is
possible to process up to 96 samples, from DNA
extract to ﬁnal fAFLP proﬁle, in <3 days, compri-
sing <1.5 days of discontinuous manual process-
ing, followed by automated fragment analysis. An
increased throughput could easily be achieved
with a higher-throughput platform. As well as
being lengthy and technically demanding, RFLP
analysis does not lend itself easily to large-batch
comparisons and inter-laboratory transfer of
results. In contrast, fAFLP analysis produces
a proﬁle of precisely-sized fragments that
(i) enables rapid interpretation and comparison
of large numbers of isolates, and (ii) is convenient
for communication of results among laboratories.
The accuracy of fragment sizing by fAFLP has
allowed common fragments to be identiﬁed,
including the 319-bp (59 isolates with 18 differ-
ent proﬁles) and 81-bp (27 isolates with 14
different proﬁles) fragments. A random subset
of the common fragments (sized within 0.5 bp
of each other) was sequenced and the fragments
were found to be identical (data not shown).
Fragment sizes observed frequently within dif-
ferent proﬁles may have arisen from the pres-
ence of IS6110 genomic hot-spots. Previously
discovered hot-spots include the DR region,
which is the common site for single-copy strains
[14], the DK1 locus [15], and the dnaA–dnaN
region [16]. Previous statistical analysis of RFLP
data from 361 isolates has identiﬁed a total of
33 and 25 potential hot-spots in Tanzanian and
London, UK strains, respectively [17]. At pre-
sent, it is unclear whether hot-spots are caused
by the preferential integration of IS elements
into these regions, or by a decreased frequency
of excision from these integration sites [14]. The
fAFLP method may inform research concerning
genomic hot-spots of IS6110 insertion and shed
light on these hypotheses. Therein also lies the
possibility of comparing differences in fre-
quency and conservation of IS6110 hot-spots
within different strains, i.e., Beijing, Haarlem,
etc., with the aim of uncovering associations
between gene disruption caused by IS6110
insertion and strain ﬁtness within genetic fam-
ilies such as the highly transmissible Beijing
clade. Improved deﬁnition of IS6110 genomic
hot-spots in the M. tuberculosis chromosome will
also provide further information on the utility of
IS6110 as an epidemiological marker. The utility
of the IS6110 element as a marker for epidemi-
ological and population studies relies on its
integration being random and biologically neut-
ral. Hot-spot integration of IS6110 will reduce
the number of different RFLP patterns pro-
duced, meaning that similar RFLP patterns
could occur more often in unrelated isolates,
potentially resulting in false case clustering [18].
With the recent description of a new MIRU-
VNTR typing panel by Supply et al. [19], in which
strain discrimination was reported to exceed that
of IS6110 RFLP analysis [19], there is potential for
IS6110 fAFLP to be useful as a secondary typing
technique for isolates that are clustered by MIRU-
VNTR typing, but which do not have any known
epidemiological links.
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SUPPLEMENTARY MATERIAL
The following supplementary material is avail-
able for this article online at http://www.black
well-synergy.com:
Fig. S1. IS6110 random fragment length poly-
morphism (RFLP) cluster analysis of 78 Myco-
bacterium tuberculosis isolates and a comparison
with ﬂuorescent ampliﬁed fragment length
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polymorphism (fAFLP) clustering and mycobac-
terial interspersed repetitive unit–variable num-
ber tandem repeat (MIRU-VNTR) analysis.
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